Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
The Australian and New Zealand Journal of Psychiatry|August 26, 2025
Association between non-adherence to fish oil or placebo as a risk factor of transition to psychosis in ultra-high-risk individuals in the NEURAPRO studyMonika Schlögelhofer, Ashleigh Lin, Connie Markulev, et al.
Annals of Neurology|September 25, 2021
Neuropathological Variability within a Spectrum of NMDAR-EncephalitisTobias Zrzavy, Verena Endmayr, Jan Bauer, et al.
JAMA Psychiatry|November 29, 2016
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical TrialPatrick D McGorry, Barnaby Nelson, Connie Markulev, et al.
Biological Psychiatry|November 7, 2019
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for PsychosisG Paul Amminger, Barnaby Nelson, Connie Markulev, et al.
Frontiers in Psychiatry|June 28, 2019
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
Translational Psychiatry|February 19, 2020
On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D<sub>2/3</sub> receptor agonist radioligand studyAna Weidenauer, Martin Bauer, Ulrich Sauerzopf, et al.
Frontiers in Psychiatry|June 30, 2020
Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
Schizophrenia Bulletin Open|August 15, 2024
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention TrialBarnaby Nelson, Hok Pan Yuen, G Paul Amminger, et al.
Schizophrenia Research|December 19, 2018
Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trialLuke K Bolt, G Paul Amminger, John Farhall, et al.
Early Intervention in Psychiatry|September 7, 2020
Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosisAlison McLaverty, Kelly A Allott, Maximus Berger, et al.
Pageof 8